The role of complex karyotype in the diagnosis of chronic lymphocytic leukemia: Integration of conventional cytogenetics and FISH analysis

https://doi.org/10.53730/ijhs.v10n3.16037

Authors

  • Irene Caliendo Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Francesco Puopolo Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Carmela Fabbricatore Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Valeria Belsito Petrizzi Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Giuseppe Malferà Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Maria Langella Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy
  • Catello Califano Hematology Unit, Hospital "Andrea Tortora", Pagani, ASL Salerno, Italy

Keywords:

chronic lymphocytic leukemia (CLL), complex karyotype (CK), conventional cytogenetic analysis (CCA), FISH, high- CK cytogenetic complexity

Abstract

Complex karyotype (CK) is an emerging high-risk feature in chronic lymphocytic leukemia (CLL). We evaluated its diagnostic and prognostic relevance by integrating conventional cytogenetic analysis (CCA) and fluorescence in situ hybridization (FISH) in 30 patients. CCA identified CK in 23% of cases, including high-complexity profiles (≥5 abnormalities). FISH detected recurrent genomic lesions with established prognostic value: del(13q), trisomy 12, del(11q), del(17p). Integrated analysis improved detection of genomic complexity and refined risk stratification beyond single-lesion assessment. A representative case highlighted the ability of combined approaches to identify high-risk CK with TP53 disruption. These findings support routine integration of CCA and FISH for comprehensive cytogenetic profiling in CLL.

Downloads

Download data is not yet available.

References

Baliakas, P., Espinet, B., Mellink, C., Jarosova, M., Athanasiadou, A., Ghia, P., ... & ERIC, the European Research Initiative on CLL. (2022). Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations. Hemasphere, 6(4), e707. DOI: https://doi.org/10.1097/HS9.0000000000000707

Baliakas, P., Jeromin, S., Iskas, M., Puiggros, A., Plevova, K., Nguyen-Khac, F., ... & Stamatopoulos, K. (2019). Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood, The Journal of the American Society of Hematology, 133(11), 1205-1216. DOI: https://doi.org/10.1182/blood-2018-09-873083

Brenner, H., Gondos, A., & Pulte, D. (2008). Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood, The Journal of the American Society of Hematology, 111(10), 4916-4921. DOI: https://doi.org/10.1182/blood-2007-12-129379

Foà, R., Del Giudice, I., Guarini, A., Rossi, D., & Gaidano, G. (2013). Clinical implications of the molecular genetics of chronic lymphocytic leukemia. Haematologica, 98(5), 675. DOI: https://doi.org/10.3324/haematol.2012.069369

Fürstenau, M., Thus, Y. J., Robrecht, S., Mellink, C. H., van der Kevie-Kersemaekers, A. M., Dubois, J., ... & Kater, A. P. (2023). High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood, 142(5), 446-459. DOI: https://doi.org/10.1182/blood.2023019634

Haferlach, C., Dicker, F., Schnittger, S., Kern, W., & Haferlach, T. (2007). Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping. Leukemia, 21(12), 2442-2451. DOI: https://doi.org/10.1038/sj.leu.2404935

Kamaso Navarro, J., Puiggros Metje, A. M., Salido Galeote, M., Melero, C., Rodríguez-Rivera, M., Gimeno Vázquez, E., ... & Espinet Solà, B. (2024). Complex karyotype detection in chronic lymphocytic leukemia: a comparison of parallel cytogenetic cultures using TPA and IL2+ DSP30 from a single center. Cancers. 2024; 16 (12): 2258. DOI: https://doi.org/10.3390/cancers16122258

Khoral, P., Atenafu, E. G., Craddock, K. J., Schimmer, A., & Chang, H. (2017). Prognostic effect of complex karyotype, monosomal karyotype, and chromosome 17 abnormalities in B-cell acute lymphoblastic leukemia. Clinical Lymphoma Myeloma and Leukemia, 17(4), 215-219. https://doi.org/10.1016/j.clml.2017.02.009 DOI: https://doi.org/10.1016/j.clml.2017.02.009

Kipps, T. J., Stevenson, F. K., Wu, C. J., Croce, C. M., Packham, G., Wierda, W. G., ... & Rai, K. (2017). Chronic lymphocytic leukaemia. Nature reviews Disease primers, 3(1), 16096. DOI: https://doi.org/10.1038/nrdp.2016.96

Pekarsky, Y., & Croce, C. M. (2015). Role of miR-15/16 in CLL. Cell Death & Differentiation, 22(1), 6-11. DOI: https://doi.org/10.1038/cdd.2014.87

Redaelli, A., Laskin, B. L., Stephens, J. M., Botteman, M. F., & Pashos, C. L. (2004). The clinical and epidemiological burden of chronic lymphocytic leukaemia. European journal of cancer care, 13(3), 279-287. DOI: https://doi.org/10.1111/j.1365-2354.2004.00489.x

Rigolin, G. M., Saccenti, E., Guardalben, E., Cavallari, M., Formigaro, L., Zagatti, B., ... & Cuneo, A. (2018). In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics. British journal of haematology, 181(2), 229-233. DOI: https://doi.org/10.1111/bjh.15174

Ripollés, L., Ortega, M., Ortuño, F., González, A., Losada, J., Ojanguren, J., ... & Caballín, M. R. (2006). Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer genetics and cytogenetics, 171(1), 57-64. https://doi.org/10.1016/j.cancergencyto.2006.07.006 DOI: https://doi.org/10.1016/j.cancergencyto.2006.07.006

Rose-Zerilli, M. J., Forster, J., Parker, H., Parker, A., Rodríguez, A. E., Chaplin, T., ... & Strefford, J. C. (2014). ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial. haematologica, 99(4), 736. DOI: https://doi.org/10.3324/haematol.2013.098574

Serafin, A., Ruocco, V., Cellini, A., Angotzi, F., Bonaldi, L., Trentin, L., & Visentin, A. (2025). Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype. British Journal of Haematology, 206(3), 832-841. DOI: https://doi.org/10.1111/bjh.19986

Strickland, S. A., Sun, Z., Ketterling, R. P., Cherry, A. M., Cripe, L. D., Dewald, G., ... & ECOG-ACRIN Cancer Research Group. (2017). Independent prognostic significance of monosomy 17 and impact of karyotype complexity in monosomal karyotype/complex karyotype acute myeloid leukemia: results from four ECOG-ACRIN prospective therapeutic trials. Leukemia research, 59, 55-64. https://doi.org/10.1016/j.leukres.2017.05.010 DOI: https://doi.org/10.1016/j.leukres.2017.05.010

Visentin, A., Bonaldi, L., Rigolin, G. M., Mauro, F. R., Martines, A., Frezzato, F., ... & Trentin, L. (2021). The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation. haematologica, 107(4), 868. DOI: https://doi.org/10.3324/haematol.2021.278304

Visentin, A., Bonaldi, L., Rigolin, G. M., Mauro, F. R., Martines, A., Frezzato, F., ... & Trentin, L. (2019). The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia. British journal of cancer, 121(2), 150. DOI: https://doi.org/10.1038/s41416-019-0502-x

Wan, T. S. (2014). Cancer cytogenetics: methodology revisited. Annals of laboratory medicine, 34(6), 413. DOI: https://doi.org/10.3343/alm.2014.34.6.413

Wan, T. S. (2017). Cancer cytogenetics: an introduction. Cancer Cytogenetics, 1-10. DOI: https://doi.org/10.1007/978-1-4939-6703-2_1

Woyach, J. A., Furman, R. R., Liu, T. M., Ozer, H. G., Zapatka, M., Ruppert, A. S., ... & Byrd, J. C. (2014). Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib. New England Journal of Medicine, 370(24), 2286-2294. DOI: https://doi.org/10.1056/NEJMoa1400029

Published

16-11-2026

How to Cite

Caliendo, I., Puopolo, F., Fabbricatore, C., Petrizzi, V. B., Malferà, G., Langella, M., & Califano, C. (2026). The role of complex karyotype in the diagnosis of chronic lymphocytic leukemia: Integration of conventional cytogenetics and FISH analysis. International Journal of Health Sciences, 10(3), 264–275. https://doi.org/10.53730/ijhs.v10n3.16037

Issue

Section

Peer Review Articles